CD4-CD8-(double negative [DN]) o~//3 T cells are a largely uncharacterized subpopulation of unknown function. To investigate whether these cells are selected to recognize particular antigens or antigen-presenting molecules, DN ot/B T ceils were purified from the peripheral blood of five normal donors and their T cell receptor (TCR) o~ and/~ chains were examined. Random cloning of TCR o~ chains by single-sided polymerase chain reaction (PCR) amplification identified an invariant rearrangement between Vot24 and Jc~Q, with no N region diversity, which was expressed preferentially by DN c~/~ T cells from all donors. Random cloning also identified a precise VoH.2-Jc~(IGRJa14) rearrangement, with two variable amino acids encoded in the V-J junction, which was enriched in the DN cr T cell preparations from some, but not all, donors. Analysis of TCR/3 chains by quantitative PCR amplification demonstrated that the expression of four Vfl gene families, V/32, 8, 11, and 13, was markedly increased in these DN c~/B T cell preparations. The expression of particular TCRs by DN ol/~ T cells from multiple donors indicates that these ceils, or at least a subpopulation of cells with this phenotype, recognize a limited spectrum of antigens and suggests that they may use nonpolymorphic antigen-presenting molecules.
H
uman peripheral blood contains small numbers ofT cells that express the TCR c~//3, lack CD4, and express low or undetectable levels of CD8 (1) (2) (3) (4) . These double-negative (DN) 1 c~/~ T cells comprise <1% of the T cells in normal peripheral blood from most donors, but their numbers may be higher in some tissues, in partictdar epidermis (5) . Increases in DN o~//3 T cells have been observed in patients with SLE (2) and systemic sclerosis (6) , in rare immunodeficient patients with a graft-vs.-host-like disease (7) , and in occasional normal donors (3) . These cells are also massively increased in Ipr and gld mice, which share features of human autoimmune disease (8, 9) . However, the normal function of DN cr cells and the role they may play in autoimmune diseases are uncertain, nor is it dear if they represent a functionally or developmentally discrete subpopulation of mature T ceUs.
A small population of mature DN c~/B T calls is also found in murine thymus (10) (11) (12) (13) (14) (15) (16) and peripheral lymphoid tissues 1 Abbreviations used in this paper: DEC, dendritic epidermal T cell; DN, double negative; HS, human serum. (15, (17) (18) (19) . Investigations of TCR V3 expression by these cells have demonstrated preferential usage of V38 in some strains of mice (10) (11) (12) 14) . A second population of murine DN or/3 T cells that preferentially expresses V32 has been demonstrated in bone marrow (20, 21) . Studies of DN c~//3 T cells in strains of mice expressing endogenous superantigens (19) and in mice with an autoreactive transgenic TCR (22, 23) suggest that these cells are selected by a mechanism different from that operating on CD4+8 -and CD4-8 + (singlepositive) T cells. These observations suggest that routine DN c~/~ T cells may represent a developmentally distinct subpopulation of T lymphocytes, perhaps mediating a specialized function.
Murine and human T cells with the DN ot/~ TCR phenotype have been identified that can carry out several effector functions (4, (24) (25) (26) (27) (28) (29) (30) (31) (32) , but the precise antigens recognized by these cells have not been defined in most cases. The absence of CD4 and CD8 expression suggests that these cells, or a subpopulation of cells with the DN cr/B TCR phenotype, may use antigen-presenting molecules other than the classical MHC class I or II proteins. Consistent with this hy-pothesis, the nonpolymorphic MHC-like CD1 molecules have been identified as the ligands for several human DN or~3 T cell clones (4, 32) .
One approach to address the question of whether specific antigens or antigen-presenting molecules are recognized by human DN o~/3 T cells is to identify the TCRs used by these cells. If the function of DN or/3 T cells involves recognition of a limited number or specific type of antigen, or if antigen presentation to these cells is carried out by proteins other than the classical MHC class I and II molecules, then the TCRs expressed by these cells may use particular V region genes or have some common structural features in their V-J joints. In this study, TCR expression by freshly isolated DN c~/~ T cells was assessed using a combination of random cloning, sequencing, and quantitative PCR amplification methods. This analysis identified at least two TCR c~ chains with distinctive structural features that were expressed preferentially by purified DN o~/3 T cells from multiple donors. VB usage by DN o~/~ T cells was also biased towards a small number of V3 gene families in each donor. These results demonstrate distinctive features of TCRs expressed by DN compared with single-positive ol//~ T cells and provide further evidence that DN c~/[3 T cells may carry out a specialized immunological function.
Materials and Methods
Isolation of DN oz/~ T Cells. Leukocyte concentrates of human peripheral blood were obtained as a byproduct of plateletpheresis of randomly selected healthy blood donors. PBMC were purified by Ficoll-Hypaque gradient centrifugation (lymphocyte separation medium; Pharmacia Fine Chemicals, Piscataway, NJ). A total of 4-14 x 10 s PBMC were suspended at 5 x 107 cells/ml in PBS containing 2% human serum (HS) and a 1:1,000 dilution of ascites fluid containing mAbs OKT4 (anti-CD4) (33) and OKT8 (antiCD8o 0 (33) , and incubated on ice for 2 h. Cells were then pdleted by centrifugation, resuspended in 25 ml of 20% rabbit serum (Accurate Chem. & Sci. Corp., Westbury, NY), diluted in RPM11640 (Gibco Laboratories, Grand Island, NY) as a source of complement activity, and incubated 1 h at room temperature followed by an additional 15 min at 37~ Viable cells were collected after complement-mediated lysis by Ficoll-Hypaque centrifugation and cultured at 2.5 x 10 s cells/ml in RPMI 1640 + 10% FCS in a single 150-cm 2 tissue culture flask. After incubation for 90 min at 37~ nonadherent cells were collected, washed, and resuspended at 5 x 107 cells/ml in PBS + 2% HS with 1:500 dilutions of ascites fluids containing mAbs OKT4, OKT8, and (in four of five preparations) anti-TCR 51 (specific for the C region of the TCR /~ chain) (34) . After incubation on ice for 1 h, the cells were washed twice and resuspended at 2 x 107 cells/ml in PBS + 2% HS containing 6 x 107/ml goat anti-mouse Ig-coupled magnetic beads (Dynabeads M450; Dynal, Inc., Great Neck, NY). The mixture of cells and magnetic beads was incubated with gentle agitation on an orbital shaker for 1 h at 4~ after which the beads and bound cells were removed by magnetic separation. Unbound cells representing purified CD4-8-nonadherent (and TCR ~5-in four of five cases) PBMC were collected, analyzed for purity by flow cytometry, and used for preparation of total cellular RNA.
Flow Cytometry Analysis. Aliquots of purified CD4-8-nonadherent PBMC and unfractionated PBMC from each donor were stained with mAbs for two-color flow cytometry analysis as previously described (35) . CD4 and CD8 expression was assessed using a mixture of FITC-conjugated mAbs Leu-3a (anti-CD4; reference 36) and B9.2 (anti-CD8~v; reference 37), each diluted to 10 #g/ml. These particular anti-CD4 and -CD8 mAbs were chosen because they bind to epitopes that are not blocked by the OKT4 and OKT8 mAbs used in the immunoselection procedure of CD4-8-cells (S. Porcelli, unpublished data). Expressions of CD3, TCR ~/~, and TCR "//5 were assessed using biotin-conjugated mAbs OKT3
(anti-CD3e; reference 33), BMA-031 (anti-TCR ~/B; reference 38) and anti-TCR 51, each diluted to 2/zg/ml. Binding of biotinylated mAbs was detected by staining with a 1:500 dilution of PEconjugated Streptavidin (Tago, Inc., Burlingame, CA). Background staining was determined using FITC and biotin conjugates of IgG1 myeloma protein P3 (39) . Immunofluorescence was analyzed using a FACScan | flow cytometer (Becton Dickinson & Co., Mountain View, CA). 10,000 cells of each sample were analyzed using forward and 90 ~ light scatter gates to select for lymphocytes.
Preparation of Whole CeUular RNA and cDNA. For each of the five different donor preparations analyzed, between 1 and 5 x 107 purified CD4-8-nonadherent PBMC were used for cDNA preparation. For each donor, an identical number of unfractionated PBMC was used. Whole cellular RNA was extracted in 3 M LiC1/6 M urea and first-strand cDNA synthesis was carried out using oligo(dT) priming and Moloney murine leukemia virus (M-MLV) reverse transcriptase (Bethesda Research Laboratories, Gaithersburg, MD), as described (40) .
Single-sided PCR Amplification and Cloning. TCR ol transcripts
were randomly cloned using a modification of the rapid amplification of cDNA ends (RACE) (41) or anchored PCR methods (42), as described previously (40) . Aliquots of cDNA from the DN cl/3
T cell preparations were homopolymer tailed with terminal deoxynucleotidyltransferase (TdT) and deoxycytosine triphosphate (dCTP), as described (40) . Second-strand synthesis was carried out using the Kienow fragment of DNA polymerase I and an oligo-(dG) primer (GATAGTCGACGGGGGGGGGG, SalI-dG10) (40). TCR ce chains were then amplified by PCR using an antisense Cce primer located at the 3' end of the C region (GAGGGAGCACA-GGCTGTCTT) and the nonspecific SalI-dG10 primer (40) . The PCR products were than reamplified using internal antisense Cc~ primers in conjunction with the SalI-dG10 primer. The internal antisense Cce primers were either GGCAGACAGACTTGTCAC-TGGAT or GAAAGTTTAGGTTCGTATC'I'G'ITI~A, located just 3' to PvulI (Col-pre-Pvu II) or HindlII sites (C~-pre-HindlII) in Cc~, respectively. The PCR products were then digested with SalI and PvulI or HindlII, and cloned into pBluescript (Stratagene, La Jolla, CA). Positive colonies were identified by hybridization with an internal C~ probe (CGGCAGGGTCAGGGTTCT) and multiple isolates were then picked and sequenced. cycles. The products were analyzed by Southern blot with an internal otigonucleotide probe (Cc~-pre-PvulI) and quantitated on a Phosphorimager (Molecular Dynamics, Inc., Sunnyvale, CA). The lower cycle number was used to quantitate; the higher cycle number was used only to confirm that the reactions had not reached a plateau at the lower number of cycles. In every experiment, the Cot amplification was repeated with each cDNA to precisely normalize for the amount of cDNA. The results were expressed as the ratio of Vot/Cot in the DN population divided by the ratio of Vot/Cot in the matched PBLs.
PCR Amplification and Cloning of Specific
To estimate the frequency of each Vot in the PBLs, the eflqciencies of the Cot versus the Vet amplification primer pairs were compared. Plasmids containing full-length Vot7.2, 23, or 24 TCK ot cDNAs (V and C region) were amplified by PCR using the pair of Cot primers or the Cc~ and appropriate Vot primers. The amount of product amplified by each primer pair, using an identical amount of template, was then compared. The efficiency of each Vot-Cot pair was calculated as the ratio of Vc~ product/Cot product. The frequency of each Vot in the PBL samples was then estimated by taking the ratio of Vot/Cot products amplified from PBL cDNA and dividing by the efficiency of the respective primer pair.
Analysis of TCRs
Amplified by PCR on High-Resolution Polyacrylamide Gels. TCR c~ chains were first amplified with the Ccz-preHindlII primer and a specific Vot primer, as described above. The PCR products (0.5/xl) were then reamplified in 20/~1 containing the same Vot primer, an internal antisense Cot primer located at the 5' end of the C region (CGGCAGGGTCAGGGTTCT, 100 ng), buffer, nucleotides, and enzyme as above, and 0.1 t*l of [32p]dCTP (3,000 Ci/mmol, 10 mCi/ml). Alternatively, in some experiments the internal Cot primer was end labeled with 32p, using polynucleotide kinase. Each cycle was 94~ for 20 s, 48~ for 30 s, and 72~ for 30 s, for 20-25 cycles. The products were denatured by heating to 80~ in 50% formamide and run on a 6% polyacrylamide DNA sequencing gel. Analysis of VB transcripts was carried out similarly using external (GCCTTTTCCCTGTGG-GAGAT) and internal (GGCTCAAACACAGCGACCT) antisense CB primers. The spacing of the TCK bands was determined by running DNA sequencing ladders next to the TCR samples.
Quantitative PCR Amplification of VI3 Transcripts. A series of VB-spedfic primers and PCR amplification were used to estimate the expression of each V/3 gene family (40, 44, 45) . The DN ot//3 T cell eDNA were amplified in a series of 30-/,1 reactions containing cDNA, 10 pmol of a CB antisense primer (GCCTTTTCCCTG-TGGGAGAT), 10 pmol ofa V/3 primer (see below), 0.1 mg/ml BSA, 0.5 U Taq polymerase (Promega Biotec), 0.2 mM dNTPS, and buffer supplied by the manufacturer. Each cycle was 94~ for 20 s, 55~ for 30 s, and 720C for 60 s. Aliquots of 5/xl were withdrawn after 24, 30, and 36 cycles and hybridized with a 32P-labeled internal antisense C/~ probe (GGCTCAAACACAGCGACCT). Quantitation was performed on a Phosphorimager (Molecular Dynamics, Inc.) after 24 or 30 cycles. The 36-cycle aliquots were useful only to confirm that the reactions had not reached a plateau at the lower cycle numbers. Each V/~ was expressed as a percent of the total product amplified by all of the V/~ primers.
One-or twofold degenerate primers were synthesized to recognize all members of each V/3 gene family (V/31-20), except V/36, which required two primers to recognize all members. The TCR nomenclature is based on reference 46, unless otherwise indicated.
The VB primers were VB1, GAGAGCAAAAGGAAACATTCT-TGAAC; V~2, GC~CACATACGAGCAAGC-CGTC; VB3, GGA-GATATTCCTGA(GA)C,-C_~TACA; V~4, CCACATATGAGAGTG-GATTTGTCA; V/~5, GATI~TCAGCTCGCCAGTTC(TC)CTA-ACT; V~6, CAGTGATCGCTTCT(TC)TGCAGA, GTC_~GG-CAGATGACTCA~q2 VB7, GCTTCTCACCTGAATGC-CCCAACA; V/38, GATAGATGATrCA~ATC~CCGA; V~9, TTATAAATGAAACAGTTCCAAATCGCT; V/310, TTCAGA-AAGCAGAAATAATCAATGAG; VEIl, GAGAAGC~AGATCTT-TCCTCTGA; V~I2, TACTGACAAAGGAGAAGTCTCAGA; V~I3, CCCT(AG)ATC.~.~TACAATGTCTCCAGAT, V/314, CI~ ATAAGGGAGAq~TTCCTGAAG; V/315, GATGTGAAAGATATA-AACAAAGGAGAGA; V~16, GATAATCTTTATCGACGTGTT-AIV_,GGA; VB17, GAAAGGAGATATAGCTGAAGGGTAC; V1318, GTCAGGAAqV~CAAAGGAACGATI~ V1319, GAAACGGAG-ATGCACAAGAAGCGA; V/320, GCCTCCAGCTGCTCTTCT-ACTCCA.
Results

Enrichment of DN ot/~ T Cells from Human Peripheral Blood. Preparations of PBLs enriched for CD4-8-TCR
or//8 + T cells (DN c~//3 T cells) from five random donors were prepared by extensive depletion of CD4 + , CDSc~ +, and plastic-adherent cells from PBMC. In four of the five preparations (donors 1-4), T cells expressing TCR 3//6 were also depleted. An example of two-color flow cytometry analysis of one representative preparation is shown in Fig. 1 , along with an identical analysis of the unfractionated PBMC for the same donor. Contrary to the earlier description of reduced TCR levels on murine peripheral lymph node DN c~/B T cells (19) , human peripheral blood DN ot/B T cells expressed the same level of TCR as did their CD4 + or CD8 + counterparts (Fig. 1) .
The enrichment of DN or//3 T calls in the CD4-and CD8-depleted preparations (DN samples) relative to the corresponding unfractionated PBMC (PBL samples) from the same donor is shown in Table 1 for each of the five preparations. DN or//3 T cells comprised <1.5% of the total lymphocytes and <2.0% of the TCK or//3 + cells in all five donor PBL samples. In the five DN samples, DN or//3 T calls accounted for >94% of the total TCR or//3 + calls, representing an enrichment of between 50-and 136-fold relative to PBL. In preparations from which TCR 7/6 + cells were specifically depleted (donors 1-4), DN or//3 T cells represented >90% of the total T cells (CD3+), whereas in the single preparation lacking depletion of TCR 3//6 + cells (donor 5), these represented 21.8% of the CD3 + cells. In all of the DN samples, the majority of the lymphocytes were CD3-, and probably represented non-T lymphocytes, including B and NK cells. Since these CD3-lymphocytes express low or undetectable levels of rearranged TCR (x or t3 chain transcripts, their presence would be predicted to have no effect on the analysis of these transcripts (47, 48) . Similarly, the presence of TCR 3,//} + cells in the DN preparation from donor 5 should not significantly affect the TCR c~/B analysis, since TCR a transcripts are absent from the vast majority of 3'//~ T cells and TCR ~ gene rearrangements are not expressed at high levels (49).
Single-sided PCR Amplification, Cloning, and Sequencing of TCR cr Chains from DN cr/fl T Cells. The initial aim was
to sample the TCR a chains expressed by DN c~/~ T cells and determine if particular Va genes were expressed at an increased frequency relative to single-positive PBLs. A concern in analyzing TCR o~ chains from minor subpopulations, such as DN ol//3 T cells, was that they could use previously undescribed Vcr genes. A single-sided PCR amplification method (40-42) was used initially, therefore, to randomly clone and sequence all potential TCR c~ chains from two preparations of DN a/~ T cells. Using this approach, it would be expected that Vex genes enriched in the DN a//3 T cell population would be found in multiple independent clones.
A total of 48 TCR cx chains were sequenced, 29 from donor I and 19 from donor 2. Two new Vc~s were identified, but they were only single isolates and their expression by DN o~//3 T cells was not, therefore, characterized further (data not shown). Three previously described Vc~s were, however, used by multiple TCRs (Table 2 ). TCKs using Va24 (43) were isolated 14 times from the first donor (48% of isolates from this donor) and once from the second donor. In the majority of these isolates from donor 1 (12/14) and in the single isolate from donor 2, Va24 was recombined with JoeQ. Moreover, no V-J junctional diversity was evident in any of these 13 Vo~24-JtxQ recombinations.
The isolation of the identical Vo~24-JoLQ recombination from donors 1 and 2 ( Table 2 ) and subsequently from three additional donors (Table 3 , see below) suggested that they may represent precise rearrangements of the germline Voe24 and JoLQ genes, with minimal or no N region additions or deletions. The germline sequence of Vc~24 is not available, but the multiple Va24 cDNA isolates in Tables 2 and 3 (see below) indicate that the 3' end of the Vol24 gene is at the AGC (encoding serine), as shown in Table 2 . The structure of the JolQ gene can be deduced from a germline Jc~Q transcript we have isolated and sequenced (Fig. 2) . Similar germline transcripts encoding other Jc~s have been described previously and presumably initiate from a promoter upstream of the unrearrangedJot gene (43, 50) . A comparison between TCR ce transcripts were cloned randomly by single-sided PCR amplification, and sequences containing Vas isolated more than once are shown. The 3' end of each Va, the N region, and the 5' end of each J region are shown along with the predicted amino acid sequence (three-letter code). The Ja nomenclature is from reference 46 unless otherwise indicated. The IGRJa1-14 sequence: and the Va7.2, 23, and 24 sequences have been described recently (43) . The complete sequences of Ja9A3 and JaSA1 will be reported elsewhere (S. P. Balk, manuscript in preparation). * Number of times each TCR was isolated.
Sequences of Vcr-Jcr Joints Containing Vots Isolated More than Once from Two DN cr/~ T Cell cDNA Libraries
Whether rearrangement is in frame ( + ) or out of frame ( -). Table 3 . TCtLs using Va24 were amplified from cDNA by PCR with Voe24 and Ca primers. Multiple isolates from each cDNA were picked and sequenced. The 3' end of Va24, the N region, and 5' end of the J region are shown. JA210 has been reported (43, 72) and the complete sequences of Ja9P251, 9P30, 8De, 8P171, and 6D10 will be reported elsewhere (S. P. Balk, manuscript in preparation). In several isolates, Va24 was spliced directly to Ca with no Ja; the 5' end of Ca is shown in these cases (underlined). * Number of times each transcript was isolated.
Nucleotide Sequences of TCRs Using Vcr24 from DN cr/fl T Cells and PBLs
Whether the rearrangement is in frame ( + ) or out of frame ( -). the Vot24-JotQ rearrangement in Table 2 and the germline JotQ gene in Fig. 2 shows that this Vot24-JotQjoint contains the entire JotQ gene segment except for the two cytosines immediately after the heptamer recombination signal. The generation of this invariant Vot24-JotQjoint required, therefore, the deletion of two bases but no N region additions.
A second Vot isolated multiple times from both donors was Vot7.2 (43) ( Table 2 ). In the majority of these TCRs, Vot7.2 was joined to IGRJa14 (43) (4/5 from donor 1 and 4/4 from donor 2). Furthermore, these V-J joints were similar in that they occurred to the same nucleotide in IGRJa14 and appeared to contain six N region nucleotides. Alternatively, the Vot7.2 gene shown in Table 2 may encode several additional 3' bases (G or GT being most likely; see below). In either case, the TCR ot chains encoded by these transcripts had the 3' alanine in Vot7.2 and two variable amino acids in the V-J junction joined precisely to the 5' aspartate in IGRJa14. Interestingly, the only Vot7.2 isolate that was joined to a different J was out of frame ( Table 2 , donor 1), further indicating that this rearrangement to IGRJa14 predominates among functional Vot7.2 rearrangements.
The third Vot identified more than once was Vot23 (43), which occurred in three isolates from each donor ( Table 2) . A previously undescribed Jot, Jot8A1, was used by one of these Vot23 TCRs from each donor, but each of these Vot23-Jot8A1 TCRs had a distinct N region and the rearrangement was out of frame in donor 1. There were otherwise no noteworthy similarities between the TCRs using Vot23.
Analysis of VotT.2, 23, and 24 Expression by Quantitative PeR
Amplification. To confirm the results from random cloning, the expression of Vot7.2, 23, and 24 by donors 1 and 2 and by three additional donors was assessed by quantitative PCR amplification. The frequency of these Vots in unfractionated PBLs from each donor was first assessed. Primers specific for Vot7.2, 23, or 24, in conjunction with a Cot primer, were used to amplify PBL cDNA from each of the donors. Two specific Cot primers were used to estimate the total amount of TCR ot cDNA, and the efficiencies of the Vot primers versus the Cot primers were determined (see Materials and Methods). This analysis indicated that the Vot7.2 transcript varied from 3.0 to 10% of the total TCR ot cDNA in PBLs from these five donors, while the Vot23 and Vot24 transcripts were between 2.2 and 6.5% (data not shown). These frequencies were consistent with the results from random cloning of TCR ot chains using these Vots from peripheral blood (43) .
The expression of these Vots in the DN population versus the PBLs from the same donor was then compared to determine if any were enriched in the DN population, cDNA from the DN and corresponding unfractionated PBL samples were used as templates for quantitative PCR amplification using primers specific for Vot7.2, 23, or 24. The amplifications were normalized in each experiment by amplifying parallel samples with two Cot primers. The amount of PCR product was quantitated and the ratio of DN versus PBL transcripts was calculated. Fig. 3 shows that the expression of Vot7.2 and Vot24 by DN ot/3 T cells was increased relative to PBLs in the majority of donors, although most of the increases were less than fourfold. In contrast, Vot23 was not increased in any of the DN ot/3 T cell preparations, indicating a discrepancy between the random cloning method ( Table 2 ) and this quantitative PCR method in assessing the expression of Vot23 by donors i and 2. The reason for this discrepancy is not clear, but it emphasizes the need for a second method to confirm results derived from random cloning. The frequencies of the Vot7.2 and Vot24 transcripts in the DN ot/3 T cell populations from donors 1 and 2 estimated by this quantitative PCR method were, however, consistent with the random cloning results ( Table 2 ). Both methods indicated that TCRs using Vot7.2 were frequent transcripts in donors 1 and 2 and that TCRs using Vot24 were particularly abundant in donor 1.
Sequence Analysis of TCR ol Transcripts from PBLs and DN ot/fl T Cells Using Vet7.2 and Vo124.
Although the expression of the Vot7.2 and Vot24 transcripts was not markedly increased in most of the DN ot/3 T cell preparations relative to the PBLs, the sequencing data in 
Sequences of TCRs Using Vot7.2 from DN at/j8 T Cells and PBLs
Precise Vc=7. 
PBL4
TCRs were amplified from eDNA by PCR using V~x7.2 and Coe primers and multiple isolates were sequenced. The majority contained the precise Va7.2-IGRJa14 joint and only the six-base (two-amino acid) V-J junctional sequences are shown for these. All of the other isolates also contained functional rearrangements and the N region and 5' end of the J region are shown for these Vot7.2 TCRs. The VAT.2 sequence in all of these extended to the TGTGCT (cysala) indicated as the 3' end of this Vot gene in Table 2 . The sequences shown here do not include those shown in Table 2 from donors 1 and 2. The complete Jot6Pa2 sequence will be reported elsewhere (S. P. Balk, manuscript in preparation).
cloned and sequenced. TCR cr transcripts were amplified by PCK from unfractionated PBLs or DN cx/fl T cells using an antisense C a primer and Vex7.2-or Vc~24-specific sense primers. The amplified TCRs were then cloned into pBluescript and multiple isolates were sequenced. Table 3 shows the N region sequence and J region usage ofVa24 TCRs from five donors. In all five DN populations, the invariant rearrangement to JotQ comprised the majority of functional TCRs. In donors 1 and 5, every isolate from the DN preparation had this rearrangement. The invariant Va24-Jc~Q rearrangement was also found in the PBL samples from all but one donor, but the frequency of this rearrangement in the PBLs was in all cases less than in the matched DN preparations. Moreover, some of the invariant Vo~24-JolQ transcripts in the unfractionated PBLs were likely de- TCRs using Va7.2 were examined similarly to determine if the precise rearrangement to IGRJa14, with two variable amino acids in the V-J junction (see Table 2 ), was enriched in the DN cx/fl T cell population. Consistent with the results in Table 2 , this precise rearrangement to IGRJa14 was found in the majority (11/12) of Vc~7.2 TCRs isolated from the DN ot/fl T cell preparations (Table 4) . However, this Vot7.2-IGRJa14 rearrangement was also found in many of the Vc~7.2 isolates from unfractionated PBLs (8/14), which contained predominantly single-positive T cells. These results showed that the Vot7.2 gene had a marked preference for this particular rearrangement to IGRJa14 in the DN c~/fl T cell populations and suggested that a similar bias was present in the single-positive T cells from some donors (see also Fig. 4 B) . Table 4 shows the junctional nucleotides and amino acids from each of the precise Vo17.2-IGRJa14 joints isolated. The two junctional amino acids were not highly conserved, although the first one was neutral in all cases and the second was neutral or basic. This larger sampling of Vcr7.2 sequences also indicated that the germline Vc~7.2 gene probably extended past the 3' alanine shown in Table 2 and includes, at least, the GTG (valine), which is shown in Tables 2 and  4 as being part of the N region. Furthermore, the finding of GTGAGA (valarg) at the 3' end of several Vc~7.2 isolates (including three that did not have the precise joint to IGRJa14) suggested that this GTGAGA was the actual 3' end of the Vex7.2 gene.
Enrichment of the Vcr24-JcrQ Rearrangement in DN cr/fl
Demonstrated by Direct Analysis of PCR Products on Denaturing Polyacrylamide Gels. To further support the results in Table   3 , that the predominant Vo~24 rearrangement in the DN cells was to JoLQ with no diversity at the V-J joint, PCR products generated with the Vex24 primer were analyzed on highresolution denaturing polyacrylamide gels (DNA sequencing gels). The PBL or DN cDNA were amplified by PCR initially with the Vc~24 primer and a Cc~ primer. Aliquots of Figure 4 . Analysis of Vo~24 and Vc~7.2 transcripts by PCR amplification and gel electrophoresis. cDNA from DN or PBL samples were amplified with a Vex24 primer (A) or Vc~7.2 primer (B) and an external Ca primer. They were reamplified using an internal Cot primer and labeled by incorporation of cx-[32p]dCTP. The labeled PCR products were then analyzed on a 6% denaturing polyacrylamide gel. these PCR products were then reamplified with the Va24 primer and an internal Cot primer, in the presence of ot.
[32p] dCTP, and analyzed on a DNA sequencing gel.
The DN ol/fl T cell cDNA from each of the donors yielded predominantly a single band (Fig. 4 A) . The size of this band was identical to the band generated by amplification from a plasmid containing the invariant Vot24-JotQ rearrangement. In contrast, the matched PBL samples showed a more heterogeneous banding pattern, consistent with the presence of N region diversity and usage of multiple J regions (Fig. 4  A) . These results were in good agreement with the sequencing data ( Table 3 ) and supported the conclusion that the invariant Voc24-JotQ rearrangement was enriched in the DN ot/fl T cell population.
A similar analysis was carried out for TCRs using the Vot7.2 gene (Fig. 4 B) . In these experiments all of the DN and PBL samples generated a prominent doublet that was identical to the doublet generated by amplification from a plasmid containing the precise Vot7.2-IGRJa14 rearrangement. The bands appear as doublets, rather than single bands, due to incomplete addition of a nontemplate-encoded adenosine at the 3' end by the Taq polymerase (51) . This incomplete addition of an adenosine at the 3' has been seen in some PCR amplifications, but not all (see Fig. 4 A) , and the variables involved are not clear.
Large doublets were also seen at intervals of three bases in most samples, indicating that they were derived from functional V-J rearrangements (Fig. 4 B) . The sequencing data in Table 4 similarly showed that most Vot7.2 rearrangements to Jots other than IGRJa14 were functional. In all cases except one (DNs from donor 3), these additional bands were significantly less intense than the Vot7.2-IGRJa14 rearrangement, particularly in the DN preparations from donors 1, 2, 4, and 5. These results demonstrated that the Vot7.2 gene had a very strong bias towards one particular type of rearrangement in both the DN and single-positive T cell populations, with an even more pronounced bias in the DN oe/fl T cell population from some, but not all, donors.
Quantitative PeR Analysis of Vj8 Usage by ON cr/B T Cells.
Further evidence that certain TCRs are used preferentially by DN ot/fl T cells was provided by an analysis of Vfl expression. Quantitative PCR amplification was performed A similar analysis from a second donor is shown in Fig.  5 , and the results from analyses of all five donors are summarized in Table 5 . These data showed a marked preference for the use of one or several Vfl genes in every donor. Moreover, the dominant Vfl gene families expressed by every donor were Vfl2, 8, 11, or 13. These results supported the conclusion that DN oL/fl T cells used certain TCRs preferentially. The 0  16  3  5  0  0  0  0  0  0  0  1  72  1  0  0  0  1  0  0  3 DN  1  8  7  2  1  5  7  37  3  1  15  2  8  1  0  0  0  0  0  0  4 DN  0  7  0  0  0  0  1  73  4  1  1  2  2  1  0  0  7  0  0  0  5 DN  0  26  0  0  3  0  2  6  1  1  33  3  16  2  2  1  3  0  0  0 finding of similar VB gene usage in multiple unrelated donors further suggested that polymorphisms in the classical MHC class I and II molecules did not influence the selection of V~ genes by these cells. Additional studies will be needed to determine if TCR ~ chains using these predominant V3 genes pair with invariant TCR ot chains or TCR o~ chains with other distinct structural features.
Assessment of v/~ Heterogendty by High-Resolution PAGE. A
gel electrophoresis method was used to determine whether the TCR-B chains using predominant V~s from each donor were monoclonal or multiclonal. The TCRs were amplified by PCR with V~2, 8, 11, or 13 primers and a C~3 primer. The PCR. products were then reamplified with the same VB primer and an internal, 32p-labeled Cj3 primer, and analyzed by gel electrophoresis. PBL cDNA was analyzed similarly with each Vfl primer. The PBL cDNA yielded multiple bands with each V~ primer (Fig. 6) , indicative of differences in length of the N region in a polyclonal population. The major PBL bands were all separated by three bases, consistent with most TCR transcripts being derived from functional rearrangements. A similar pattern was seen for the DN TCR B chains using VBll, indicating that multiple DN ol/B T cell clones using VBll were present. In contrast, several predominant bands were detected among the DN TCR B chains using V~2, 8, and 13, suggesting an oligoclonal expansion of T cells using these VBs. Taken The invariant Vc~24-Jo~Q TCR found increased in each DN o~/B T cell preparation was most likely generated by the removal of two bases from the germline J~Q gene, with no N region additions. These invariant voL24-JolQ TCRs could be derived from a single expanded clone in each donor, but their occurrence in all donors suggests that this rearrangement occurs in multiple independent clones in each donor. Examples of invariant TCR chains with no N region additions have been described for certain 3'/~ T cells. Murine dendritic epidermal T cells (DECs) express invariant TCR 3' and chains that are generated by independent recombination events in multiple clones (52, 53) . In humans, a significant proportion of the joints between V79 and JTP are generated by the excision of a single J'yP-encoded base, with no N region additions (54) . Whether this invariant V79-JTP rearrangement occurs in one or multiple independent clones has not been determined.
The relatively high frequency of these invariant Vc~24-Jo~Q TCRs in multiple donors indicates that some mechanism exists that favors their occurrence. Although this mechanism may be simply positive selection of randomly generated clones, a number of factors could increase the frequency of this rearrangement directly. For example, the germline V~24 andJo~Q genes may be particularly accessible to each other due to close physical proximity or because they become activated for recombination at the same time during development. The lack of template-independent insertions in the invariant Vo~24-Jo~Q TCR could be due to development of DN ol/~ T cells in Figure 6 . Analysis of VB transcripts by PCR amplification and gel electrophoresis, eDNA was amplified with Vj3 primers and a CB primer and then reamplified using an internal, a2p-labeled CB primer. The labeled PCR products were analyzed on a 6% denaturing polyacrylamide gel. The V~ primers used and the sources of the cDNA are indicated. the thymus before TdT is active, as is the case for the invariant TCR 3' and/t chains of murine DECs (55, 56) . If the high frequency of the invariant Vt~24-Jc~Q joint is indeed due to these or other mechanisms operating to favor invariant Vot-Jot recombinations in DN or//3 T cells, then TCKs with other invariant germline Vc~-Jc~ joints may be present and predominate in the DN or/3 T cells from other donors. Random TCR c~ cloning from additional DN or/3 T cell preparations and further information on genomic Vot and Jot sequences will be necessary to address this question.
An alternative possibility is that invariant Vct24-JctQjoints could be generated at random in the thymus and then undergo positive selection followed by ligand-dependent donal expansion in the periphery. The ligands recognized by DECs or by TCtLs using the invariant Vot24-JaQ or V3'9"Jq'P rearrangements have not been identified. The expression of the Vct24-JctQ TCR in multiple donors suggests that the ligand, or at least the epitope, recognized by this TCR is nonpolymorphic. Similar arguments have been made for the ligands recognized by DECs (52, 53, 57) and the Vq'9-J3'P recombination (54) . If the ligand recognized by the vot24-JolQ TCR is an MHC class I or II molecule or a nonpolymorphic MHC class I-like molecule, then the lack of CD4 or CD8 expression may be necessary to prevent autoreactivity. Analysis of T cell clones using this invariant Vc~24-Jc~Q TCR will be necessary to identify the ligand recognized by this TCR and determine if it arises in multiple independent clones in each donor.
A second interesting group of TCR o~ chains identified in these studies were recombinations between Vct7.2 and IGRJa14. These Vc~7.2-IGRJa14joints were enriched in some, but not all, DN a/B T cell preparations. In the majority of DN c~//~ T cells and unfractionated PBLs using VotT.2, the joint was to the same nucleotide in IGRJa14 with two variable amino acids in the V-J junction. The conserved structure of this Vct7.2-IGRJa14 joint in multiple clones from five donors suggests that this TCR a chain may be selected by a nonpolymorphic ligand. Nonpolymorphic MHC class I-like (58) or class II-like (59, 60) molecules are candidate ligands, as these Vc~7.2-IGRJa14 TCRs are expressed by singlepositive as well as DN T cells. Alternatively, the Vc~7.2 gene may have a structural limitation such that only these particular recombinations with IGRJa14 allow it to fold correctly and undergo positive selection by conventional MHC molecules. A similar recombination between murine Vot14 and Jol281 with a one-base N region has been demonstrated in multiple strains of mice, and these TCRs appear to be positively selected by a non-MHC-linked monomorphic ligand (61) .
The analysis of TCR ~ chains provided further evidence that DN ot/~ T cells use particular TCRs preferentially. The majority of DN c~/B T cells from each donor used only one or two VB gene families, with the predominant VBs being V~2, 8, 11, and 13 (Table 5 ). Further analysis of these TCR chains on DNA sequencing gels indicated that they were less heterogeneous than the corresponding TCRs from PBLs. This suggests that their expansion was probably not due to VB-specific polyclonal stimulation by a superantigen (62) , although the possibility that chronic stimulation by super- 13 Porcelli et al.
antigens might result in this pattern of restricted TCR expression cannot be ruled out. The preferential expression of these V/3s by DN t~/~ T cells from multiple unrelated donors suggests, therefore, that these cells may recognize a limited number of conventional antigens and may use nonpolymorphic antigen-presenting molecules. Alternatively, if the TCR B chains using these predominant VBs are paired with invariant TCR c~ chains or other TCR cr chains with particular structural features, then the ability to pair with these TCR ot chains could be the major factor responsible for selecting these V/~s. Normal mice also have a small population of mature DN ct//3 T cells (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) that preferentially use the V~8 gene family (10-12, 14, 16) , but the function of these cells and their relationship to single-positive ct/B T cells have not been resolved (16, 19, 22, 23, 63, 64) . Studies of the CDdct gene in DN ol/B cells have shown that this gene is demethylated at some sites, providing evidence that it was expressed at one point by these cells (16, 65) . However, the demethylation pattern appears to be less complete in DN ot/B thymocytes than in CD4 single-positive cells, suggesting that DN c~//3 T cells never fully expressed the CDdct gene (65) . A recent report demonstrates that CD4-CD8 l~ thymocytes, which have been proposed as the immediate precursors of CD4 + CD8 + thymocytes, express low levels of functional ot/~ TCRs and that ligation of their TCRs blocks their expression of CD4 and CDd, but does not lead to cell death (66) . Taken together, these observations suggest that CD4-CD81~ thymocytes expressing TCRs with a high affinity for some intrathymic antigens could be the precursors of mature DN ot/~ T cells (67) .
The antigens recognized by murine DN o~/B T cells have not been identified, but candidate ligands for these cells in humans are the MHC-like CDla, b, and c proteins, which are expressed by immature thymocytes (68) (69) (70) . DN c~//3 T cell clones that specifically lyse target cells expressing CDla (4, 32) or CDlc (4), with no apparent requirement for an exogenous antigen, have been isolated from human peripheral blood. A possible function for such CDl-specific DN t~/B T cells could be the elimination of malignant or autoimmune immature T cells that escape from the thymus into the periphery. DN or//3 T cells that display CDlb-restricted recognition of a processed mycobacterial antigen have also been described (4), suggesting a role for these cells in immunity to microbial pathogens. Our finding that TCRs expressed by DN or//3 T cells have restricted V gene usage and distinctive structural features in their V-J junctions, in conjunction with these observations on CD1 recognition, provide further evidence for the hypothesis that a significant proportion of T cells lacking CD4 and CD8 recognize antigen-presenting molecules other than the classical MHC class I and II proteins.
DN ct//5 T cells are increased in some patients with SLE (2) and systemic sclerosis (6) , and restricted VB gene usage has been reported in the latter disease (6) . However, the relationship between these DN ct/B T cells in autoimmune diseases and in normal peripheral blood is unclear, nor is it known if DN or//3 T cells play a direct causative role in these diseases. Mice with the Ipr defect, caused by a mutant Fas gene (71) , similarly have a SLE-like disease and greatly increased numbers of DN el/fl T cells (8) . This suggests that expansion of DN c~/fl T cells in some cases may be secondary to an underlying immunological defect causing autoimmunity, rather than a primary cause of the disease. Nevertheless, further studies on the relationship between expansion of DN c~/fi T cells and autoimmune disease are warranted and could lead to important insights into the function of these cells. The data in this report on the structure of the TCRs expressed by DN oe//3 T cells in normal peripheral blood provide a useful baseline against which the structure of these TCRs in various diseases can be compared.
